TMCR Extends Closing to Double Mesabi Royalty to 2.0%
TMCR sits 21% above its 52-week low of $5.14.
Summary
TMCR extended the closing deadline for its additional 1.0% Mesabi royalty to August 15, 2026, with an option to August 21. The deal would double its royalty to 2.0%, targeting ~$22M annual cash flow, as the project advances toward Q4 2026 first production.
Key Events · M&A and Partnerships · TMCR
-
Additional Royalty Closing Extended
The closing deadline for the additional 1.0% Mesabi royalty has been pushed to August 15, 2026, with a further extension option to August 21, 2026, on the same economic terms as the initial acquisition.
-
Royalty Doubles to 2.0%
Once closed, TMCR's total royalty interest in the Mesabi Project will double to 2.0%, bringing anticipated annual royalty cash flow of approximately $22 million at 7.28 Mtpa, with a pathway to $26 million at 8.5 Mtpa.
-
Project Construction Milestones
The Concentrator Control Room has been commissioned and is now operational, and the Primary Crusher Building has completed its start-up trial run, keeping the project on track for full commissioning in Q3 and first production in Q4 2026.
-
Financing Risk Noted
The filing cautions that TMCR may be unable to obtain financing on acceptable terms or at all, and any financing could be dilutive, though no specific financing plan is disclosed.
Analysis · TMCR · Energy & Transportation
By extending the closing deadline for the additional 1.0% royalty, the deal remains on course to double TMCR's total royalty to 2.0% and lift anticipated annual cash flow to roughly $22 million. Meanwhile, project milestones—the control room is commissioned and the crusher trial run is complete—signal that construction is nearing the finish line, with first production still on track for Q4 2026. Together, these developments reduce near-term uncertainty around the royalty's value and reinforce the growth trajectory.
At the time of this filing, TMCR was trading at $6.20 on NASDAQ in the Energy & Transportation sector, with a market capitalization of approximately $384.7M. The 52-week trading range was $5.14 to $21.38. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.